Skip to main content

Ally Bridge Group (NY) LLC

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1822947 NEW YORK, NY

Position in EWTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,384,479
-$1,687,021 QoQ
Shares Held
83,300
-48.3% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
4.36%
of 13F equity value
Holder Rank
#78
of 223 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EWTX Over Time

Shares Held

Position Value (USD)

Derivatives in EWTX

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$6,203,750
PutShares
250,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ally Bridge Group (NY) LLC holds $75,058,438 across 22 Biotechnology names. EWTX ranks #7 (4.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 EWTX
Edgewise Therapeutics, Inc.
This page
83,300 $3,384,479

All Filings in EWTX

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,384,479 83,300
2026-03-31 $5,071,500 161,000
2025-12-31 $6,203,750 250,000
2025-12-31 $4,838,925 195,000
2025-03-31 $2,258,300 102,650
2024-12-31 $2,220,799 83,176
2024-09-30 $5,009,579 187,695